8-K
filed July 20, 2023, 7:59 PM ET
ticker HRGN
CIK 0001563665
other material
confidence high
sentiment neutral
materiality 0.35
Harvard Apparatus Regenerative (fka Biostage) trades under HRGN; FDA clears 10-patient phase 1 esophageal study
Harvard Apparatus Regenerative Technology, Inc.
- Name changed from Biostage to Harvard Apparatus Regenerative Technology; new ticker HRGN on OTCQB effective July 20, 2023.
- FDA approved a 10-patient phase 1 study for esophageal implant; enrollment opened.
- Company plans to launch anti-aging business in China; expects it to be cash flow positive in fiscal 2023.
- Launched new website www.hregen.com to highlight regenerative technology and anti-aging strategy.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Harvard Apparatus Regenerative Technology, Inc.: Amended and restated Bylaws solely to reflect the name change to Harvard Apparatus Regenerative Technology, Inc (effective 2023-07-20).
- Change
- bylaw amendment
- Effective
- 2023-07-20
Exact text from the filing
The Company also amended and restated its Amended and Restated Bylaws, solely to reflect the name change (as amended, the “Third Amended and Restated Bylaws”). The Certificate of Amendment and the Third Amended and Restated Bylaws each became effective on July 20, 2023.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Harvard Apparatus Regenerative Technology, Inc.: Amended Certificate of Incorporation to change company name from Biostage, Inc. to Harvard Apparatus Regenerative Technology, Inc (effective 2023-07-20).
- Change
- charter amendment
- Effective
- 2023-07-20
Exact text from the filing
Harvard Apparatus Regenerative Technology, Inc. (the “Company”) filed an amendment (the “Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) with the Secretary of State for the State of Delaware to change its name from Biostage, Inc. to Harvard Apparatus Regenerative Technology, Inc. The Company also amended and restated its Amended and Restated Bylaws, solely to reflect the name change (as amended, the “Third Amended and Restated Bylaws”). The Certificate of Amendment and the Third Amended and Restated Bylaws each became effective on July 20, 2023.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.